-
CVS looks to 2023 after opioids settlement, Medicare rating decline
Nov 2 (Reuters) – CVS Overall health Corp (CVS.N) on Wednesday forecast a 2023 profit under Wall Road estimates and said it hoped to mitigate the strike from a performance score decrease for its most common Medicare system by encouraging members to change to other ideas. The organization also announced it agreed to pay about $5 billion around 10 decades to take care of 1000’s of lawsuits accusing its pharmacy chain of mishandling opioid painkillers. examine extra CVS took a pre-tax cost of $5.2 billion in the 3rd quarter associated to the settlement, a shift that finishes yrs of uncertainty for the firm’s finances. The settlement price tag, which was…